Amarin Reports First Quarter 2019 Financial Results and Provides Update on Operations

NEXT STORY
MediPharm Labs Appoints Renowned Medical Expert and Pharmaceutical Researcher Dr. Paul Tam to its Board of Directors
PREV STORY
Motif Bio Signs Agreement with Lamellar Biomedical
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Amarin Reports First Quarter 2019 Financial Results and Provides Update on Operations

NEXT STORY
MediPharm Labs Appoints Renowned Medical Expert and Pharmaceutical Researcher Dr. Paul Tam to its Board of Directors
PREV STORY
Motif Bio Signs Agreement with Lamellar Biomedical
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA

author_avatar
NASDAQ Market News

Cerecor Announces Successful Proof of Concept Data for CERC-002, a Unique LIGHT-Neutralizing Antibody, in Patients Hospitalized with COVID-19 ARDS

author_avatar
NASDAQ Market News

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

author_avatar
NASDAQ Market News